New Antibiotics for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia

Matteo Bassetti(University of Udine), Antonio Vena(Ospedale Policlinico San Martino), Nadia Castaldo(Ospedale Santa Maria della Misericordia di Udine), Alessandra Mularoni(Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), Daniele Roberto Giacobbe(Ospedale Policlinico San Martino)
Seminars in Respiratory and Critical Care Medicine
January 27, 2022
10.1055/s-0041-1740605
Cited by 66

Related Papers

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone Resistance
|JAMA|2018|761
How to manage Pseudomonas aeruginosa infections
|Drugs in Context|2018|743
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data
|The Lancet Respiratory Medicine|2014|648
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>
|Clinical Infectious Diseases|2018|351